The recent filing of group litigation in the High Court of England and Wales against Johnson & Johnson and Kenvue Limited marks the UK's first large-scale legal action over alleged asbestos contamination in talc-based personal care products - an event that insurance and legal experts say could have significant implications for liability coverage, long-tail reserving, and corporate reputation.
The claim, brought by approximately 3,000 individuals represented by KP Law, follows similar cases filed in the US and other jurisdictions. It alleges that long-term use of talc-based products, including baby powder, exposed consumers to asbestos fibres that contributed to serious illnesses such as ovarian cancer and mesothelioma. The alleged exposure period spans from 1965 to 2023, when sales of talc-based baby powder were discontinued in the UK .
While the full particulars of the claim have not yet been made public, reports indicate that claimants are bringing actions under negligence, breach of statutory duty and strict liability under the Consumer Protection Act of 1987. They allege that the defendants failed to test, warn or adequately control contamination risks, which J&J has consistently denied.
According to HCR Law, the case represents a key test for the insurance market. Jonathan Edwards, partner and head of insurance and risk, and Polly Sayers, foreign registered solicitor in the insurance and risk and regulatory team, said the action "sharpens key liability, coverage, and reputational challenges that insurers will need to manage as the action progresses."
They noted that causation will likely form the core of the dispute. Claimants must establish both general causation and specific causation.
"Expert evidence across mineralogy, industrial hygiene, and oncology will be central to both liability and coverage, limitation risk and its financial impact," they said.
HCR Law also warned that while insurers may seek to rely on broad asbestos exclusions in liability policies, the scope of these clauses could be tested if claimants frame allegations around "talc-only" theories of harm. The firm further noted that limitation arguments, under the Limitation Act 1980 and the Consumer Protection Act 1987, could materially affect insurers' exposure, though courts may show flexibility given the latency of diseases and evolving scientific understanding.
Beyond coverage and cost, Edwards and Sayers cautioned that the reputational risk linked to this litigation is significant.
"Cost risk stems from prolonged, expert-heavy proceedings and contested causation," they said. "[R]eputational risk flows from the consumer-facing nature of the products and the sensitivity of the allegations." they said.
They added that insurers should closely track how courts handle causation, limitation, and exclusion interpretation as the case unfolds.
"Insurers should combine coverage evaluation with measured communication and prudent reserving, preparing for outcomes shaped by law, science and public perception," they said.
